Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Syngene concludes acquisition of biologics manufacturing facility from Stelis Biopharma

Ruchika Sharma4 Dec 2023 3:00 PM IST

Bangalore: Syngene International has announced the conclusion of the acquisition of a multi-modal biologics manufacturing facility from Stelis...

Granules India subsidiary bags USFDA nod for Sildenafil for Oral Suspension

Ruchika Sharma4 Dec 2023 1:30 PM IST

Sildenafil for Oral Suspension is indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] Group I) in...

AstraZeneca, Jacobio Pharma ink pact for proprietary Pan-KRAS inhibitor

AstraZeneca signs USD 247 million deal with Absci to design antibody for cancer: Report

Ruchika Sharma4 Dec 2023 12:30 PM IST

United Kingdom: Anglo-Swedish drugmaker AstraZeneca has signed a deal worth up to $247 million with U.S. artificial intelligence (AI) biologics firm...

Genmab, AbbVie Face Setback as Epcoritamab Misses Survival Goal in Lymphoma Study

AbbVie to acquire ImmunoGen, including its flagship cancer therapy Elahere

Ruchika Sharma4 Dec 2023 11:30 AM IST

North Chicago, Ill.: AbbVie Inc. and ImmunoGen, Inc. have announced a definitive agreement under which AbbVie will acquire ImmunoGen, and its flagship...

Boehringer Ingelheim, AnGes sign manufacturing agreement for HGF gene therapy product

Bayer, CrossBay Medical to develop novel Intrauterine System Inserter

Ruchika Sharma4 Dec 2023 10:00 AM IST

Berlin: Bayer and CrossBay Medical Inc., have announced a development and option to license agreement that will allow the development and...

India, US agree to strengthen cooperation in pharma

Ruchika Sharma3 Dec 2023 4:30 PM IST

Raimondo announced the inclusion of four new members in the forum from the US industry including Honeywell, Pfizer, Kyndryl, and Viasat.

JnJ appoints Eugene A Woods to its Board of Directors

Ruchika Sharma3 Dec 2023 12:45 PM IST

New Brunswick: Johnson & Johnson has announced that Eugene A. Woods, MBA, MHA, Chief Executive Officer of Advocate Health, has been appointed...

USFDA nod to JnJ Tremfya for Crohns disease

Johnson & Johnson MedTech buys Laminar for USD 400 million

Ruchika Sharma3 Dec 2023 12:30 PM IST

New Brunswick: Johnson & Johnson MedTech has announced the completion of the acquisition of Laminar, Inc., a privately-held medical device...

From Breakthrough to Backlash: Novo Nordisks Ozempic Faces USD 2 Billion Lawsuit

Suspected fake Ozempic causes hypoglycemia in 11 in Lebanon

Ruchika Sharma3 Dec 2023 10:00 AM IST

Lebanon: Eleven people suffered bouts of dangerously low blood sugar in Lebanon this year, one of whom required hospitalization, after injecting...

USFDA nod to Padcev plus Keytruda for certain patients with Bladder cancer: Pfizer, Astellas Pharma

Pfizer drops twice daily version of obesity pill over side effects

Ruchika Sharma2 Dec 2023 4:24 PM IST

New York: Pfizer said on Friday it would not advance a twice-daily version of oral weight-loss drug danuglipron into late-stage studies after...

Merck application for Keytruda plus Padcev for Urothelial Cancer gets USFDA priority review

Ruchika Sharma2 Dec 2023 2:30 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has accepted...

Eli Lilly joins trillion-dollar club, fueled by weight loss drug demand boom

Eli Lilly secures USFDA nod for leukemia treatment Jaypirca

Ruchika Sharma2 Dec 2023 1:30 PM IST

This is the second FDA-approved indication for Jaypirca following the January 2023 Accelerated Approval for the treatment of adult patients with...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok